Not bad. Revenue as per last year, but NPAT by nearly 25% increased!
Result Summary:
Operating Revenue in line with last year at $570m2
Operating Profit (EBIT) up 13% to $35.1m
Net Profit After Tax Attributable to Shareholders up 24% to 16.8m
Pharmacy Operating Revenue down 6% and Operating Profit at $24.1m
Medical continued to grow, with Operating Revenue up 7% and Operating Profit $9.3m
Community Health Operating Revenue up 10% and Operating Profit $3.7m.
No divie though "to preserve cash to assist the Company with accelerating its acquisition activities"
PE is 9.3 and EPS CAGR (both averaging over the last 10 years) was 8.9; Not too bad - a health company with quite healthy earnings and still consistently growing them. Move to doctors and community services in my view a good idea. Feels undervalued by the market.
